News Image

Shareholder Alert: Ademi LLP investigates whether Rain Oncology Inc. has obtained a Fair Price in its transaction with Pathos

Provided By PR Newswire

Last update: Dec 14, 2023

MILWAUKEE, Dec. 14, 2023 /PRNewswire/ -- Ademi LLP is investigating Rain (NASDAQ: RAIN) for possible breaches of fiduciary duty and other violations of law in its transaction with Pathos.

Read more at prnewswire.com

RAIN ENHANCEMENT TECHNO-CL A

NASDAQ:RAIN (9/23/2025, 8:06:21 PM)

5.27

+0.15 (+2.93%)



Find more stocks in the Stock Screener

Follow ChartMill for more